Dextroamphetamine Sulfate 13107-0035
Product NDC
13107-0035- Manufacturer
- Aurolife Pharma, Llc
- Dosage Form
- Tablet
- Route
- Oral
- Product Type
- Human Prescription Drug
- DEA Schedule
- Schedule CII
- Marketing Start
- July 31, 2013
- Listing Expires
- December 31, 2026
- Application
- ANDA202893
Active Ingredients
| Ingredient | Strength |
|---|---|
| Dextroamphetamine Sulfate | 5 mg/1 |
Drug Class
Central Nervous System Stimulant [EPC]Central Nervous System Stimulation [PE]
Packaging Options(3)
100 TABLET in 1 BOTTLE (13107-035-01)
50 TABLET in 1 BOTTLE (13107-035-50)
1000 TABLET in 1 BOTTLE (13107-035-99)